SUNNYVALE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and preventive health company, ...

The primary logo features the fan-favorite bear with the rolling Smoky Mountains. The Smokies script sits on top of the ...

AI-enhanced manufacturing applications are now being deployed around the world as a massive upgrade in efficiency.

The British pharma’s experience during the third quarter mirrored that of rival Pfizer, which also reported lower sales of ...

GSK Plc acquired an experimental drug from Chinese biotech firm Chimagen Biosciences for as much as $850 million, adding to the British drugmaker’s pipeline of potential treatments for lupus.

Read Bolt CEO's full memo to staff: Following up from the All-hands on Tuesday I'll explain my thinking about the new Return to Office & Location policy and your role as a manager in supporting ...

GSK plc announced new preliminary data for Arexvy (respiratory syncytial virus vaccine, recombinant adjuvanted) in adults aged 18-49 at increased risk for RSV-LRTD due to certain underlying medical ...

The funding, which brings GSK’s expenditure in US manufacturing capabilities close to $1.3bn, will establish a new vaccines drug substance facility and an R&D pilot plant. Pennsylvania Governor Josh ...

US pharma major GSK (LSE: GSK) yesterday announced new preliminary data for Arexvy (respiratory syncytial virus vaccine, recombinant adjuvanted) in adults aged 18-49 at increased risk for RSV-LRTD due ...

IN MARIETTA, L Hundreds of millions of dollars and hundreds of new jobs are coming to Lancaster County.Vaccine manufacturer GSK announced Thursday it will invest $800 million to expand its ...

GSK is investing up to $800 million to double the size and capacity of its production site in Marietta, Pennsylvania, the company said Thursday. Through the addition of two new facilities ...

Preliminary results from two trials showed that GSK’s respiratory syncytial virus ... the shot for a larger population. In one of the new Arexvy trials, a single dose triggered robust immune ...